Automated instrumentation for production of t-cell receptor peptide libraries

Abstract

The present disclosure provides instrumentation and automated methods for creating cell surface display libraries, where the cells of the library display engineered peptides on their cell surfaces for identification of antigens that bind to T-cell receptors. The engineered peptides may be putative antigens or binding regions of the T-cell receptors.

We claim: 
     
         1 . An automated method of creating a cell library expressing engineered peptides using instrumentation, the method comprising:
 providing a population of cells;   processing the population of cells using an instrument for multiplexed nuclease-directed genome editing using introduced nucleic acids and a nucleic acid-directed nuclease to create cells comprising nucleic acids that encode engineered peptides configured to be displayed on a surface of the cells;   incubating the processed cells to facilitate nucleic acid editing in the cells, wherein the editing provides nucleic acids that encode engineered peptide antigens in the cells; and   allowing the cells to express and display the engineered peptides on the surface of the cells.   
     
     
         2 . The method of  claim 1 , wherein the engineered peptides are putative TCR binding antigens 
     
     
         3 . The method of  claim 1 , wherein the engineered peptides comprise predicted TCR binding regions. 
     
     
         4 . The method of  claim 1 , wherein the population of cells are yeast cells. 
     
     
         5 . The method of  claim 1 , wherein the nuclease is an RNA-directed nuclease. 
     
     
         6 . An automated method of creating a cell library expressing engineered putative T-cell receptor (TCR) antigens on the surface of the cells, the method comprising:
 providing a population of cells;   processing the population of cells using an instrument for multiplexed nuclease-directed genome editing using introduced nucleic acids and a nuclease to create cells comprising nucleic acids that encode engineered peptide antigens configured to be displayed on a surface of the cells;   incubating the processed cells to facilitate nucleic acid editing in the cells, wherein the editing provides nucleic acids that encode engineered peptide antigens in the cells; and   allowing the cells to express and display the engineered peptide antigens that are putative TCR antigens on the surface of the cells.   
     
     
         7 . The method of  claim 6 , wherein the population of cells are yeast cells. 
     
     
         8 . The method of  claim 6 , wherein the population of cells are mammalian cells. 
     
     
         9 . The method of  claim 6 , wherein the cells display the engineered peptide antigens are displayed on the cells as part of a ligand. 
     
     
         10 . The method of  claim 6 , wherein the cells co-express putative TCR antigens and MHC molecules. 
     
     
         11 . The method of  claim 6 , wherein the nuclease is a nucleic acid-directed nuclease. 
     
     
         12 . The method of  claim 6 , wherein the nuclease is an RNA-directed nuclease. 
     
     
         13 . The method of  claim 6 , wherein one or more of the engineered peptide antigens are putative antigens of one or more orphan TCRs. 
     
     
         14 . The method of  claim 6 , wherein one or more of the engineered peptide antigens are known antigens of one or more TCRs. 
     
     
         15 . An automated, multiplexed method for identifying peptides that selectively bind one or more T-cell receptors (TCRs), the method comprising:
 providing a population of cells;   processing the population of cells using an automated system for multiplexed nuclease-directed genome editing, wherein the system comprises the steps of:   introducing nucleic acids that encode engineered peptide antigens and a nuclease to a population of cells;   incubating the cells to facilitate nucleic acid editing in the cells; and   allowing the edited cells to express and display the engineered peptide antigens on the surface of the edited cells;   screening the edited cells displaying the engineered peptide antigens against one or more TCRs; and   identifying the edited cells expressing engineered peptide antigens that selectively bind to one or more TCRs.   
     
     
         16 . The method of  claim 15 , further comprising isolating the nucleic acids encoding the engineered peptide antigens that selectively bind to one or more TCRs from the cells. 
     
     
         17 . The method of  claim 15 , wherein the nuclease is a nucleic acid-directed nuclease. 
     
     
         18 . The method of  claim 15 , wherein the nuclease is an RNA-directed nuclease. 
     
     
         19 . The method of  claim 15 , wherein the cells encoding engineered peptide antigens are identified and/or isolated a barcode associated with the engineered peptide antigens. 
     
     
         20 . A cell library produced using the method of  claim 1 .